Group Information: A list of the IMAGEN Consortium investigators appears at www.imagen-europe.com.
Submitted for Publication: July 20, 2012; final revision received October 17, 2012; accepted December 11, 2012.
Published Online: June 19, 2013. doi:10.1001/jamapsychiatry.2013.44.
Study concept and design: Müller, Barker, Büchel, Conrod, Fauth-Bühler, Flor, Garavan, Heinz, Mann, Pausova, Rietschel, Ströhle, Paus, Smolka.
Acquisition of data: Müller, Mennigen, Ripke, Banaschewski, Büchel, Conrod, Flor, Garavan, Heinz, Lawrence, Loth, Mann, Rietschel, Struve, Walaszek, Schumann, Martinot.
Analysis and interpretation of data: Müller, Ripke, Banaschewski, Conrod, Paus, Smolka.
Drafting of the manuscript: Müller, Heinz, Smolka.
Critical revision of the manuscript for important intellectual content: Mennigen, Banaschewski, Barker, Büchel, Conrod, Fauth-Bühler, Flor, Garavan, Heinz, Lawrence, Loth, Mann, Martinot, Pausova, Rietschel, Ströhle, Struve, Walaszek, Schumann, Paus, Smolka.
Statistical analysis: Müller, Ripke, Garavan, Smolka.
Obtained funding: Büchel, Flor, Mann, Martinot, Rietschel, Ströhle, Struve, Schumann, Paus, Smolka.
Administrative, technical, and material support: Mennigen, Banaschewski, Barker, Büchel, Conrod, Fauth-Bühler, Flor, Lawrence, Mann, Rietschel, Ströhle, Struve, Schumann.
Study supervision: Flor, Heinz, Mann, Rietschel, Struve, Paus, Smolka.
Conflict of Interest Disclosures: Dr Banaschewski reports serving in an advisory or consultancy role for Bristol-Myers Squibb, Develco Pharma, Lilly, Medice, Novartis, Shire, and Viforpharma; receiving conference attendance support and conference support or speaker’s fees from Lilly, Janssen McNeil, Medice, Novartis, and Shire; and current or previous involvement in clinical trials conducted by Lilly and Shire. Dr Barker reports receiving honoraria for teaching from General Electric.
Funding/Support: This study was supported by the IMAGEN project, which receives research funding LSHM-CT-2007-037286 from the European Community’s Sixth Framework Program, by grant 242257 from coordinated project Alzheimer’s Disease, Alcoholism, and Memory; by MRC program grant 93558 (Developmental Pathways Into Adolescent Substance Abuse); by European Union Innovative Medicine Initiative AIMS (European Autism Interventions: a Multicentre Study for Developing New Medications); and by grant 2012-23 (Unifying Epigenetic and Genetic Approach to Psychiatric Disorders in Children and Adolescents) from the Swedish Funding Agency FORMAS. This study was also supported by grant 01EV0711 from the German Ministry of Education and Research and grant SM 80/7-1 from the Deutsche Forschungsgemeinschaft.
Role of the Sponsors: The funding agencies had no role in the design and conduct of the study; in the collection, analysis, and interpretation of the data; or in the preparation, review, or approval of the manuscript.
Disclaimer: This article reflects only the authors’ views and the IMAGEN Consortium is not liable for any use that may be made of the information contained therein.